phase ii metabolism of drugs
Metabolism
Clinical trials are the mechanism for improved survival and quality of life for individuals facing a cancer diagnosis. Without proof, we would know that mastectomy for breast cancer is equivalent to lumpectomy and axillary node dissection. We would not have the evidence that most patients with Hodgkin's Lymphoma Non-Hodgkin's lymphoma, advanced testicular cancer can be cured with chemotherapy. To achieve these milestones in the successful treatment of cancer, cancer clinical trials are designed in a step-wise fashion.
Phase I: The first step in testing a new approach in humans. Data laboratory animals and previous studies are used to evaluate the dose, dosing, drug metabolism and side effects. Patients were divided in small groups called "cohorts." Each cohort is treated with increasing doses of the agent or combination to the maximum tolerated dose is reached. The highest (or more effective) doses associated with acceptable side effects is chosen for further study. Generally, Phase I trials are conducted in patients with various malignant tumors with advanced illness.
Phase II trials: Determination of safety and efficacy of a new treatment are the primary objectives of Phase II. A new medication, a combination or technique is studied in a small and relatively homogeneous group of patients (eg, 40 to 100 patients with a specific type cancer). The type of cancer treatment chosen for Phase II is based on the results of laboratory studies and Phase I trials. The main objective of most of phase II clinical trials of cancer is to determine the percentage of patients showing a measurable response to treatment. Additional information on side effects and security are also collected.
Phase III trials: These large-scale trials comparing a new treatment or combination that has shown promise in trials Phase II to the current standard. Patients are randomized to the standard approach or the new treatment. Phase III trials are critical for advancing the quality cancer treatment and can set a new standard of care. Hundreds of thousands of participants may be necessary for the proper designed Phase III trial.
Experimental or research (definition of the National Cancer Institute): A research study or clinical trial referred to a drug (including a new drug, dose, combination, or route of administration) or procedure that has undergone basic laboratory testing and received approval Food and Drug Administration (FDA) to be tested in humans. A drug or procedure may be approved by the FDA for use in a disease or condition, but is considered investigational in other diseases or conditions. Different insurance companies may have different definitions for these terms.
Medicare and clinical trials: Medicare reimburses for the routine treatment of cancer and the care that is part of a clinical trial. Covered services include Routine diagnostic tests, procedures, medical visits, medication administration expenses in research and treatment and hospitalization if necessary to manage side effects. Items that are not reimbursed include any charge for an investigational drug, services or items provided free for a sponsor, or any coinsurance or deductible payment. Since most insurance companies follow Medicare guidelines, the same provisions to cover the costs of clinical trials must be approved by private health insurers.
By providing coverage of treatment in a clinical trial nationally sanctioned, public and private insurers are allowing their subscribers to access high quality, state of the art therapies. Clinical trials help to identify better and safer anti-cancer drugs. Advances in treatment occur as a direct result of clinical trials. These developments lead to new rules care and improved quality of life of those battling cancer. New and more effective therapies will result in a reduction in relapse rates and suffering suffered by cancer victims and their families. Moreover, the success of clinical trials will contribute to a reduction in health care rose dollars to fight against two the number of deaths in the United States. Reducing the burden of cancer requires a dedicated system of health care that supports research as the only way to improve outcomes and save lives.
Applications of Genetic Tools to Clinical and Translational Research
Category: metabolism
Leave a Reply